The leading causes of death in the United States have changed significantly from the year 1900 to the present. Leading causes of death in 1900, such as tuberculosis, gastrointestinal infections, and diphtheria have seen huge decreases in death rates and are no longer among the leading causes of death in the United States. However, other diseases such as heart disease and cancer have seen increased death rates. Vaccinations One major factor contributing to the decrease in death rates for many diseases since the year 1900 is the introduction of vaccinations. The decrease seen in the rates of death due to pneumonia and influenza is a prime example of this. In 1900, pneumonia and influenza were the leading causes of death, with around *** deaths per 100,000 population. However, in 2023 pneumonia and influenza were not even among the ten leading causes of death. Cancer One disease that has seen a large increase in death rates since 1900 is cancer. Cancer currently accounts for almost ** percent of all deaths in the United States, with death rates among men higher than those for women. The deadliest form of cancer for both men and women is cancer of the lung and bronchus. Some of the most common avoidable risk factors for cancer include smoking, drinking alcohol, sun exposure, and obesity.
The leading causes of death in the United States are heart disease and cancer. However, in 2022, COVID-19 was the fourth leading cause of death in the United States, accounting for around six percent of all deaths that year. In 2022, there were around 45 deaths from COVID-19 per 100,000 population.
Cardiovascular disease
Deaths from cardiovascular disease are more common among men than women but have decreased for both sexes over the past few decades. Coronary heart disease accounts for the highest portion of cardiovascular disease deaths in the United States, followed by stroke and high blood pressure. The states with the highest death rates from cardiovascular disease include Oklahoma, Mississippi, and Alabama. Smoking tobacco, physical inactivity, poor diet, stress, and being overweight or obese are all risk factors for developing heart disease.
Cancer
Although cancer is the second leading cause of death in the United States, like deaths from cardiovascular disease, deaths from cancer have decreased over the last few decades. The highest death rates from cancer come from lung cancer for both men and women. Breast cancer is the second deadliest cancer for women, while prostate cancer is the second deadliest cancer for men. West Virginia, Mississippi, and Kentucky lead the nation with the highest cancer death rates.
As of 2022, the third leading cause of death among teenagers aged 15 to 19 years in the United States was intentional self-harm or suicide, contributing around 17 percent of deaths among age group. The leading cause of death at that time was unintentional injuries, contributing to around 37.4 percent of deaths, while 21.8 percent of all deaths in this age group were due to assault or homicide. Cancer and heart disease, the overall leading causes of death in the United States, are also among the leading causes of death among U.S. teenagers. Adolescent suicide in the United States In 2021, around 22 percent of students in grades 9 to 12 reported that they had seriously considered attempting suicide in the past year. Female students were around twice as likely to report seriously considering suicide compared to male students. In 2022, Montana had the highest rate of suicides among U.S. teenagers with around 39 deaths per 100,000 teenagers, followed by South Dakota with a rate of 33 per 100,000. The states with the lowest death rates among adolescents are New York and New Jersey. Mental health treatment Suicidal thoughts are a clear symptom of mental health issues. Mental health issues are not rare among children and adolescents, and treatment for such issues has become increasingly accepted and accessible. In 2021, around 15 percent of boys and girls aged 5 to 17 years had received some form of mental health treatment in the past year. At that time, around 35 percent of youths aged 12 to 17 years in the United States who were receiving specialty mental health services were doing so because they had thought about killing themselves or had already tried to kill themselves.
Rank, number of deaths, percentage of deaths, and age-specific mortality rates for the leading causes of death, by age group and sex, 2000 to most recent year.
In the United States, the leading causes of death among women are heart disease and cancer. Heart disease and cancer are similarly the leading causes of death among U.S. men. In 2022, heart disease accounted for **** percent of all deaths among women in the United States, while cancer accounted for **** percent of deaths. COVID-19 was the third leading cause of death among both men and women in 2020 and 2021, and the fourth leading cause in 2022. Cancer among women in the U.S. The most common types of cancer among U.S. women are breast, lung and bronchus, and colon and rectum. In 2025, there were around ******* new breast cancer cases among women, compared to ******* new cases of lung and bronchus cancer. Although breast cancer is the most common form of cancer among women in the United States, lung and bronchus cancer causes the highest number of cancer deaths. In 2025, around ****** women were expected to die from lung and bronchus cancer, compared to ****** from breast cancer. Breast cancer Although breast cancer is the second most deadly form of cancer among women, rates of death have decreased over the past few decades. This decrease is possibly due to early detection, progress in therapy, and increasing awareness of risk factors. In 2023, the death rate due to breast cancer was **** per 100,000 population, compared to a rate of **** per 100,000 in the year 1990. The state with the highest rate of deaths due to breast cancer is Oklahoma, while South Dakota had the lowest rates.
The deadliest animals in the world based on the number of human deaths per year is not a creature that humans usually find scary, such as a lion or snake. Mosquitos are by far the deadliest creature in the world when it comes to annual human deaths, causing around one million deaths per year, compared to 100,000 deaths from snakes and 250 from lions. Perhaps surpringly, dogs are the third deadliest animal to humans. Dogs are responsible for around 30,000 human deaths per year, with the vast majority of these deaths resulting from rabies that is transmitted from the dog.
Malaria
Mosquitos are the deadliest creature in the world because they transmit a number of deadly diseases, the worst of which is malaria. Malaria is a mosquito-borne disease caused by a parasite that results in fever, chills, headache, vomiting and, if left untreated, death. Malaria disproportionately affects poorer regions of the world such as Africa and South-East Asia. In 2020, there were around 627,000 deaths from malaria worldwide.
Mosquito-borne diseases in the U.S.
The most common mosquito-borne diseases reported in the United States include West Nile virus, malaria, and dengue viruses. Many of these cases, however, are from travelers who contracted the disease in another country - this is especially true for malaria, Zika, and dengue. In 2018, the states of California, New York, and Texas reported the highest number of mosquito-borne disease cases in the United States.
Heart conditions were the most common causes of death in Mexico in 2023. During that period, more than ******* people died in the North American country as a result from said conditions. Diabetes mellitus ranked second, with over ******* deaths registered that year. Obesity in MexicoObesity and being overweight can worsen many risk factors for developing heart conditions, prediabetes, type 2 diabetes, and gestational diabetes, which in the case of a COVID-19 infection can lead to a severe course of the disease. In 2020, Mexico was reported as having one of the largest overweight and/or obese population in Latin America, with ** percent of people in the country having a body mass index higher than 25. In 2022, obesity was announced as being one of the most common illnesses experienced in Mexico, with over ******* cases estimated. In a decade from now, it is predicted that about *** million children in Mexico will suffer from obesity. If estimations are correct, this North American country will belong to the world’s top 10 countries with the most obese children in 2030. Physical activity in MexicoIt is not only a matter of food intake. A 2023 survey found, for instance, that only **** percent of Mexican population practiced sports and physical activities in their free time, a figure that has decreased in comparison to 2013. Less than ** percent of the physically active Mexicans practice sports for fun. However, the vast majority were motivated by health reasons.
The burden of influenza in the United States can vary from year to year depending on which viruses are circulating, how many people receive an influenza vaccination, and how effective the vaccination is in that particular year. During the 2023-2024 flu season, around 28,000 people lost their lives to the disease. Although most people recover from influenza without needing medical care, the disease can be deadly among young children, the elderly, and those with weakened immune systems or chronic illnesses. Deaths due to influenza Even though most people recover from influenza without medical care, influenza and pneumonia can be deadly, especially for older people and those with certain preexisting conditions. Influenza is a common cause of pneumonia and although most cases of influenza do not develop into pneumonia, those that do are often more severe and more deadly. Deaths due to influenza are most common among the elderly, with a mortality rate of around 32 per 100,000 population during the 2023-2024 flu season. In comparison, the mortality rate for those aged 50 to 64 years was 9.1 per 100,000 population. Flu vaccinations The most effective way to prevent influenza is to receive an annual influenza vaccination. These vaccines have proven to be safe and are usually cheap and easily accessible. Nevertheless, every year a large share of the population in the United States still fails to get vaccinated against influenza. For example, in the 2022-2023 flu season, only 35 percent of those aged 18 to 49 years received a flu vaccination. Unsurprisingly, children and the elderly are the most likely to get vaccinated. It is estimated that during the 2022-2023 flu season, vaccinations prevented over 929 thousand influenza cases among children aged 6 months to 4 years.
Attribution-NonCommercial 3.0 (CC BY-NC 3.0)https://creativecommons.org/licenses/by-nc/3.0/
License information was derived automatically
This item contains all data and statistical code to replicate the analysis presented in the preprint entitled "Using rapid online surveys to assess perceptions during infectious disease outbreaks: a cross-sectional survey on Covid-19 among the general public in the United States and United Kingdom".
Background: Given the extensive time needed to conduct a nationally representative household survey and the commonly low response rate in phone surveys, rapid online surveys may be a promising method to assess and track knowledge and perceptions among the general public during fast-moving infectious disease outbreaks. Objective: To apply rapid online surveying to determine knowledge and perceptions of coronavirus disease 2019 (Covid-19) among the general public in the United States (US) and the United Kingdom (UK). Methods: An online questionnaire was administered to 3,000 adults residing in the US and 3,000 adults residing in the UK who had registered with Prolific Academic to participate in online research. Strata by age (18 - 27, 28 - 37, 38 - 47, 48 - 57, or 58 years), sex (male or female), and ethnicity (White, Black or African American, Asian or Asian Indian, Mixed, or “Other”), and all permutations of these strata, were established. The number of participants who could enrol in each of these strata was calculated to reflect the distribution in the US and UK general population. Enrolment into the survey within the strata was on a first-come, first-served basis. Participants completed the questionnaire between February 23 and March 2 2020. Results: 2,986 and 2,988 adults residing in the US and the UK, respectively, completed the questionnaire. 64.4% (1,924/2,986) of US and 51.5% (1,540/2,988) of UK participants had a tertiary education degree. 67.5% (2,015/2,986) of US participants had a total household income between $20,000 and $99,999, and 74.4% (2,223/2,988) of UK participants had a total household income between £15,000 and £74,999. US and UK participants’ median estimate for the probability of a fatal disease course among those infected with SARS-CoV-2 was 5.0% (IQR: 2.0% – 15.0%) and 3.0% (IQR: 2.0% – 10.0%), respectively. Participants generally had good knowledge of the main mode of disease transmission and common symptoms of Covid-19. However, a substantial proportion of participants had misconceptions about how to prevent an infection and the recommended care-seeking behavior. For instance, 37.8% (95% CI: 36.1% – 39.6%) of US and 29.7% (95% CI: 28.1% – 31.4%) of UK participants thought that wearing a common surgical mask was ‘highly effective’ in protecting them from acquiring Covid-19. 25.6% (95% CI: 24.1% – 27.2%) of US and 29.6% (95% CI: 28.0% – 31.3%) of UK participants thought it prudent to refrain from eating at Chinese restaurants. Around half (53.8% [95% CI: 52.1% – 55.6%] of US and 39.1% [95% CI: 37.4% –40.9%] of UK participants) thought that children were at an especially high risk of death when infected with SARS-CoV-2. Conclusions: The distribution of participants by total household income and education followed approximately that of the general population. The findings from this online survey could guide information campaigns by public health authorities, clinicians, and the media. More broadly, rapid online surveys could be an important tool in tracking the public’s knowledge and misperceptions during rapidly moving infectious disease outbreaks.
This dataset contains counts of deaths for California as a whole based on information entered on death certificates. Final counts are derived from static data and include out-of-state deaths to California residents, whereas provisional counts are derived from incomplete and dynamic data. Provisional counts are based on the records available when the data was retrieved and may not represent all deaths that occurred during the time period. Deaths involving injuries from external or environmental forces, such as accidents, homicide and suicide, often require additional investigation that tends to delay certification of the cause and manner of death. This can result in significant under-reporting of these deaths in provisional data.
The final data tables include both deaths that occurred in California regardless of the place of residence (by occurrence) and deaths to California residents (by residence), whereas the provisional data table only includes deaths that occurred in California regardless of the place of residence (by occurrence). The data are reported as totals, as well as stratified by age, gender, race-ethnicity, and death place type. Deaths due to all causes (ALL) and selected underlying cause of death categories are provided. See temporal coverage for more information on which combinations are available for which years.
The cause of death categories are based solely on the underlying cause of death as coded by the International Classification of Diseases. The underlying cause of death is defined by the World Health Organization (WHO) as "the disease or injury which initiated the train of events leading directly to death, or the circumstances of the accident or violence which produced the fatal injury." It is a single value assigned to each death based on the details as entered on the death certificate. When more than one cause is listed, the order in which they are listed can affect which cause is coded as the underlying cause. This means that similar events could be coded with different underlying causes of death depending on variations in how they were entered. Consequently, while underlying cause of death provides a convenient comparison between cause of death categories, it may not capture the full impact of each cause of death as it does not always take into account all conditions contributing to the death.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
We describe the results of a prospective observational study of the clinical natural history of human monkeypox (mpox) virus (MPXV) infections at the remote L’Hopital General de Reference de Kole (Kole hospital), the rainforest of the Congo River basin of the Democratic Republic of the Congo (DRC) from March 2007 until August 2011. The research was conducted jointly by the Institute National de Recherche Biomedical (INRB) and the US Army Medical Research Institute of Infectious Diseases (USAMRIID). The Kole hospital was one of the two previous WHO Mpox study sites (1981–1986). The hospital is staffed by a Spanish Order of Catholic Nuns from La Congregation Des Soeurs Missionnaires Du Christ Jesus including two Spanish physicians, who were members of the Order as well, were part of the WHO study on human mpox. Of 244 patients admitted with a clinical diagnosis of MPXV infection, 216 were positive in both the Pan-Orthopox and MPXV specific PCR. The cardinal observations of these 216 patients are summarized in this report. There were three deaths (3/216) among these hospitalized patients; fetal death occurred in 3 of 4 patients who were pregnant at admission, with the placenta of one fetus demonstrating prominent MPXV infection of the chorionic villi. The most common complaints were rash (96.8%), malaise (85.2%), sore throat (78.2%), and lymphadenopathy/adenopathy (57.4%). The most common physical exam findings were mpox rash (99.5%) and lymphadenopathy (98.6%). The single patient without the classic mpox rash had been previously vaccinated against smallpox. Age group of less than 5 years had the highest lesion count. Primary household cases tended to have higher lesion counts than secondary or later same household cases. Of the 216 patients, 200 were tested for IgM & IgG antibodies (Abs) to Orthopoxviruses. All 200 patients had anti-orthopoxvirus IgG Abs; whereas 189/200 were positive for IgM. Patients with hypoalbuminemia had a high risk of severe disease. Patients with fatal disease had higher maximum geometric mean values than survivors for the following variables, respectively: viral DNA in blood (DNAemia); maximum lesion count; day of admission mean AST and ALT.
https://www.marketreportanalytics.com/privacy-policyhttps://www.marketreportanalytics.com/privacy-policy
The global Yellow Fever Virus Testing market is experiencing robust growth, driven by increasing incidence of yellow fever outbreaks, particularly in endemic regions of Africa and South America. The market's expansion is fueled by rising awareness of the disease, improved diagnostic capabilities, and enhanced public health initiatives focused on vaccination and surveillance. Several factors contribute to market growth, including the development of more sensitive and rapid diagnostic tests like PCR-based assays and advancements in point-of-care diagnostics that facilitate faster diagnosis in remote areas. The market is segmented by application (clinical diagnostics, scientific research) and test type (virus nucleic acid detection, antibody testing, virus isolation, and others). While nucleic acid detection methods dominate currently due to high sensitivity, antibody testing is gaining traction due to its ease of use and cost-effectiveness in large-scale screening programs. Market restraints include the high cost of advanced diagnostic technologies, limited healthcare infrastructure in endemic regions, and challenges associated with sample collection and transportation in remote locations. Despite these challenges, the market is projected to witness significant growth over the forecast period (2025-2033), fueled by increasing investments in research and development, collaborations between public health organizations and diagnostic companies, and growing government initiatives to control yellow fever outbreaks. Major players like Altona Diagnostics, Liferiver, and Thermo Fisher Scientific are actively involved in developing and commercializing innovative diagnostic solutions, contributing to market expansion. The North American and European markets currently hold a significant share due to well-established healthcare infrastructure and high diagnostic testing rates. However, growth in Asia-Pacific and Africa is expected to be significant, driven by rising disease prevalence and increasing healthcare expenditure in these regions. The competitive landscape features a mix of established players and emerging companies. Large multinational corporations are focusing on expanding their product portfolios and geographical reach, while smaller companies are specializing in niche technologies and applications. Strategic collaborations, mergers and acquisitions are anticipated as companies seek to gain market share and expand their offerings. Future market growth will be contingent upon factors such as government funding for disease control programs, development of affordable and accessible diagnostic tools, and continued advancements in diagnostic technologies. Effective public health strategies and improved healthcare infrastructure are crucial for ensuring widespread access to reliable Yellow Fever Virus Testing, thereby mitigating the impact of this potentially fatal disease.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Sub-Saharan Africa represents 69% of the total number of individuals living with HIV infection worldwide and 72% of AIDS deaths globally. Pulmonary infection is a common and frequently fatal complication, though little is known regarding the lower airway microbiome composition of this population. Our objectives were to characterize the lower airway microbiome of Ugandan HIV-infected patients with pneumonia, to determine relationships with demographic, clinical, immunological, and microbiological variables and to compare the composition and predicted metagenome of these communities to a comparable cohort of patients in the US (San Francisco). Bronchoalveolar lavage samples from a cohort of 60 Ugandan HIV-infected patients with acute pneumonia were collected. Amplified 16S ribosomal RNA was profiled and aforementioned relationships examined. Ugandan airway microbiome composition and predicted metagenomic function were compared to US HIV-infected pneumonia patients. Among the most common bacterial pulmonary pathogens, Pseudomonas aeruginosa was most prevalent in the Ugandan cohort. Patients with a richer and more diverse airway microbiome exhibited lower bacterial burden, enrichment of members of the Lachnospiraceae and sulfur-reducing bacteria and reduced expression of TNF-alpha and matrix metalloproteinase-9. Compared to San Franciscan patients, Ugandan airway microbiome was significantly richer, and compositionally distinct with predicted metagenomes that encoded a multitude of distinct pathogenic pathways e.g secretion systems. Ugandan pneumonia-associated airway microbiome is compositionally and functionally distinct from those detected in comparable patients in developed countries, a feature which may contribute to adverse outcomes in this population.
The leading causes of death among Black residents in the United States in 2022 included diseases of the heart, cancer, unintentional injuries, and stroke. The leading causes of death for African Americans generally reflects the leading causes of death for the entire United States population. However, a major exception is that death from assault or homicide is the seventh leading cause of death among African Americans, but is not among the ten leading causes for the general population. Homicide among African Americans The homicide rate among African Americans has been higher than that of other races and ethnicities for many years. In 2023, around 9,284 Black people were murdered in the United States, compared to 7,289 white people. A majority of these homicides are committed with firearms, which are easily accessible in the United States. In 2022, around 14,189 Black people died by firearms. However, suicide deaths account for over half of all deaths from firearms in the United States. Cancer disparities There are also major disparities in access to health care and the impact of various diseases. For example, the incidence rate of cancer among African American males is the greatest among all ethnicities and races. Furthermore, although the incidence rate of cancer is lower among African American women than it is among white women, cancer death rates are still higher among African American women.
https://dataintelo.com/privacy-and-policyhttps://dataintelo.com/privacy-and-policy
The global Diphtheria, Tetanus, and Pertussis (DTaP) vaccine market size is poised to witness significant growth from 2024 to 2032, with an estimated market value of $4.9 billion in 2023 and a forecasted value of approximately $8.3 billion by 2032, growing at a compounded annual growth rate (CAGR) of 6.2%. This impressive growth trajectory is primarily driven by the continuous advancements in vaccine technology, increasing awareness about vaccine-preventable diseases, and the robust initiatives undertaken by both governmental and non-governmental organizations to increase immunization coverage worldwide. The ongoing development of healthcare infrastructure, particularly in emerging economies, further contributes to the promising outlook for the DTaP vaccine market.
A key growth factor for the DTaP vaccine market is the rising incidence of pertussis and other related infections, which has heightened the demand for effective immunization programs. In recent years, outbreaks of pertussis have been reported in both developed and developing regions, underscoring the need for comprehensive vaccination strategies. This scenario has led to increased governmental and public health efforts to ensure widespread vaccine accessibility and coverage, thereby bolstering market growth. Moreover, the increasing recognition of the importance of booster doses in maintaining immunity levels across different age groups has further fueled the market demand for DTaP vaccines.
Another significant driver of market growth is the technological advancements in vaccine production, which have resulted in safer and more efficacious vaccines. The development of acellular vaccines, which are associated with fewer side effects compared to whole-cell vaccines, has been a pivotal factor in increasing vaccine acceptance and compliance. Furthermore, ongoing research and development activities are focused on enhancing vaccine formulations and delivery mechanisms, ensuring the continued relevance and effectiveness of the DTaP vaccines. These innovations are attracting significant investments from both public and private sectors, thereby further securing the market's growth trajectory over the forecast period.
The supportive policies and funding from international organizations and governments also play a crucial role in propelling the growth of the DTaP vaccine market. Various initiatives, such as the World Health Organization's Expanded Programme on Immunization and national vaccination programs, have been instrumental in enhancing the reach and uptake of DTaP vaccines. Additionally, collaborations between vaccine manufacturers and public health agencies aimed at improving vaccine production and distribution capabilities are expected to further stimulate market expansion. Together, these factors create an ecosystem that is conducive to sustained growth in the global DTaP vaccine market.
The Tetanus Vaccine, a crucial component of the DTaP combination, plays a significant role in preventing tetanus, a potentially fatal disease caused by the bacterium Clostridium tetani. This vaccine is essential not only for children but also for adults, particularly those in high-risk occupations or environments where injuries are common. The importance of the Tetanus Vaccine is underscored by its inclusion in routine immunization schedules worldwide, ensuring that populations are protected against this serious infection. As part of the broader DTaP vaccine, the Tetanus Vaccine contributes to the overall effectiveness of immunization programs aimed at reducing the incidence of vaccine-preventable diseases. Its role in maintaining public health is further emphasized by the ongoing efforts to improve vaccine formulations and accessibility, ensuring that individuals across different regions have access to this life-saving intervention.
Regionally, North America and Europe have been at the forefront of the DTaP vaccine market due to well-established healthcare infrastructure and high awareness levels about immunization. However, the Asia Pacific region is projected to exhibit the highest growth rate, driven by substantial improvements in healthcare access and increasing governmental focus on immunization programs. The region's large population base, coupled with rising healthcare expenditure and advancements in vaccine distribution networks, contribute to this optimistic regional outlook. As countries in Asia Pacific continue to prioritize vaccination as part of their public health agendas, the region is expec
Cardiovascular Medical Devices Market Size 2025-2029
The cardiovascular medical devices market size is forecast to increase by USD 21.71 billion at a CAGR of 7.6% between 2024 and 2029.
The market is driven by the escalating incidence of cardiovascular diseases and the expansion of insurance providers' coverage for related treatments. Market players are responding with innovative business strategies, including product development and strategic collaborations, to capitalize on these opportunities. However, the high cost of cardiovascular procedures poses a significant challenge for both patients and providers, potentially limiting market growth. Artificial intelligence and wireless technologies, such as Al-based electrocardiograms, implantable loop recorders, and event monitors, are also gaining popularity for their ability to improve diagnostic accuracy and patient care.
Effective cost management and continuous innovation will be essential for market success. As the population ages and cardiovascular diseases become increasingly prevalent, companies must navigate this financial obstacle while maintaining quality and affordability to meet patient needs and remain competitive. Companies in this market are focusing on innovative technologies like Al and machine learning based electrocardiogram (ECG) technology to improve the accuracy and efficiency of cardiovascular diagnosis.
What will be the Size of the Cardiovascular Medical Devices Market during the forecast period?
Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample
The Cardiovascular Devices Market encompasses diagnostic monitoring devices, surgical devices, and cardiology devices used to prevent and manage heart disorders, including cardiomyopathy, heart failure, stroke, and heart-related mortality. According to the World Health Organization, cardiovascular diseases are the leading cause of death worldwide, making this market crucial for addressing healthcare resources and improving patient outcomes. Emerging nations are increasingly investing in advanced cardiovascular devices, such as AI-based ECG technology and minimally invasive procedures, to reduce fatal conditions like heart failure and stroke. The market is witnessing significant trends, including the integration of artificial intelligence in diagnostics and the development of more sophisticated surgical devices, such as coronary artery stents.
Cardiovascular Diseases, including heart disorders and heart-related mortality, are major health concerns, and the demand for diagnostic monitoring devices, such as Holter monitors, is on the rise. The market's growth is driven by the need for early detection and effective management of cardiovascular conditions, as well as advancements in technology, such as minimally invasive procedures and AI-based electrocardiogram technology. The Cardiovascular Devices Market is expected to continue growing, as healthcare systems in both developed and emerging nations seek to improve patient care and reduce the burden of cardiovascular diseases. With advancements in technology and a growing focus on preventative care, the market is poised for continued growth and innovation.
How is this Cardiovascular Medical Devices Industry segmented?
The cardiovascular medical devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.
Product
Diagnostic systems
Surgical devices
Disease Type
Coronary artery disease
Arrhythmia
Heart failure
Structural heart disease
Others
End-user
Hospitals
ASCs
Specialty clinics
Home healthcare settings
Rehabilitation centers
Geography
North America
US
Canada
Mexico
Europe
France
Germany
Italy
UK
APAC
China
India
Japan
Rest of World (ROW)
By Product Insights
The Diagnostic systems segment is estimated to witness significant growth during the forecast period. The market encompasses a vast array of technologies and devices designed to diagnose, monitor, and treat heart disorders and diseases. This market includes innovative solutions such as AI-based electrocardiogram (ECG) technology, implantable loop recorders, cardiac CT scans, and minimally invasive procedures for detecting clogged arteries and assessing heart function. Valves, pacemakers, stents, Holter monitors, and electrosurgical procedures are among the essential cardiovascular devices used for treating various heart conditions. The World Health Organization reports that cardiovascular diseases (CVDs) are the leading cause of heart-related mortality worldwide. Fatal conditions like atrial fibrillation, stroke, and heart
In the United States in 2021, the death rate was highest among those aged 85 and over, with about 17,190.5 men and 14,914.5 women per 100,000 of the population passing away. For all ages, the death rate was at 1,118.2 per 100,000 of the population for males, and 970.8 per 100,000 of the population for women. The death rate Death rates generally are counted as the number of deaths per 1,000 or 100,000 of the population and include both deaths of natural and unnatural causes. The death rate in the United States had pretty much held steady since 1990 until it started to increase over the last decade, with the highest death rates recorded in recent years. While the birth rate in the United States has been decreasing, it is still currently higher than the death rate. Causes of death There are a myriad number of causes of death in the United States, but the most recent data shows the top three leading causes of death to be heart disease, cancers, and accidents. Heart disease was also the leading cause of death worldwide.
The leading causes of death among the white population of the United States are cardiovascular diseases and cancer. Cardiovascular diseases and cancer accounted for a combined **** percent of all deaths among this population in 2022. In 2020 and 2021, COVID-19 was the third leading cause of death among white people. Disparities in causes of death In the United States, there exist disparities in the leading causes of death based on race and ethnicity. For example, chronic liver disease and cirrhosis is the ***** leading cause of death among the white population and the ****** among the Hispanic population, but is not among the ten leading causes for Black people. On the other hand, homicide is the ******* leading cause of death among the Black population, but is not among the 10 leading causes for whites or Hispanics. However, cardiovascular diseases and cancer by far account for the highest share of deaths for every race and ethnicity. Diseases of despair The American Indian and Alaska Native population in the United States has the highest rates of death from suicide, drug overdose, and alcohol. Together, these three behavior-related conditions are often referred to as diseases of despair. Asians have by far the lowest rates of death due to drug overdose and alcohol, as well as slightly lower rates of suicide.
The death rate from Parkinson’s disease has gradually increased over the last decade. Parkinson’s disease is a nervous system disorder that progressively impacts movement. Symptoms include tremors, slowed movement, rigid muscles, speech changes and the loss of automatic movements. These symptoms start mildly but become more severe as the disease progresses. Parkinson’s disease death Parkinson’s disease is usually not considered a deadly disease, and many people with the disease have relatively normal life expectancies. Death from Parkinson’s disease results from complications arising from advanced symptoms, such as problems swallowing or falls. Therefore, the death rate from Parkinson’s disease increases significantly with age. Living with Parkinson’s disease It is predicted that by the year 2030 there will be around *** million people living with Parkinson’s disease in the United States. A survey of Parkinson’s disease patients showed that some of the most common symptoms from the disease included fatigue, tremors or shaking, trouble sleeping, and changes in handwriting. Common cognitive changes involved concentration and attention span, verbal fluency, information processing, and memory.
In 2022, the most significant cause of death among men in the United States was heart disease, which contributed to 22.5 percent of deaths. COVID-19 was the third leading cause of death among U.S. men in both 2020 and 2021, and the fourth leading cause in 2022. This statistic shows the distribution of the 10 leading causes of death among men in the United States from 2020 to 2022.
The leading causes of death in the United States have changed significantly from the year 1900 to the present. Leading causes of death in 1900, such as tuberculosis, gastrointestinal infections, and diphtheria have seen huge decreases in death rates and are no longer among the leading causes of death in the United States. However, other diseases such as heart disease and cancer have seen increased death rates. Vaccinations One major factor contributing to the decrease in death rates for many diseases since the year 1900 is the introduction of vaccinations. The decrease seen in the rates of death due to pneumonia and influenza is a prime example of this. In 1900, pneumonia and influenza were the leading causes of death, with around *** deaths per 100,000 population. However, in 2023 pneumonia and influenza were not even among the ten leading causes of death. Cancer One disease that has seen a large increase in death rates since 1900 is cancer. Cancer currently accounts for almost ** percent of all deaths in the United States, with death rates among men higher than those for women. The deadliest form of cancer for both men and women is cancer of the lung and bronchus. Some of the most common avoidable risk factors for cancer include smoking, drinking alcohol, sun exposure, and obesity.